• Publications and Articles Trending in Science and Technology

on: Last Sunday
by: Boston Herald

Casgevy: CRISPR-Cas9 Mechanism for Restoring Fetal Hemoglobin

6

Casgevy utilizes CRISPR-Cas9 to target the BCL11A gene, prompting fetal hemoglobin production to treat Sickle Cell Disease and Beta Thalassemia.